CNBC 快讯 5月16日 12:33 强生新银屑病药物Icotyde或成重磅炸弹——投资者重估营收增长轨迹 Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever Investors are counting drugs like Icotyde to accelerate J&J's revenue growth rate. FG 100 读报告 →